Replies to post #8016 on BioCurex, Inc.(fka BOCX)

[longterm42]

you have your opinion and i have mine.

[onco]

wanna bet. the ins co will demand screen prior to more expensive test. it will be in very heavy use. besides if the other test only used we still win .no?

[HALF FULL GLASS]

Gold, Have you ever had a rapid Strep test done when you went to urgent care?

you know...just before you ask for amoxaciline regardless of the outcome of the test.

This looks to be very similar but it will be a rapid cancer test.

[Headache]

Wrong. Look at the PSA test, which has become a routine screening tool in spite of its inaccuracy. A cheap point of care test for cancer could no doubt become a routine part of every apparently healthy person's yearly physical exam. Why order a more expensive test unless cancer is suspected in an individual or the individual belongs to a high-risk cohort. This is an excellent concept that fits with diagnostic tools that are currently being used for other conditions.

Is anyone out there a relatively healthy younger person who has had a routine physical exam lately? Check your lab test document to see the types of tests the doctor has ordered. That's where the RECAF point of care test will go.